MedPath

Peter Merkel

🇩🇪Germany
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:1

Trial Phases

0 Phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Clinical Transcriptomics in Systemic Vasculitis (CUTIS)

Recruiting
Conditions
IgA Vasculitis
Microscopic Polyangiitis (MPA)
Granulomatosis With Polyangiitis (GPA)
Drug-induced Vasculitis
Polyarteritis Nodosa (PAN)
Cryoglobulinemic Vasculitis (CV)
Urticarial Vasculitis
Vasculitis
Eosinophilic Granulomatosis With Polyangiitis (EGPA)
Isolated Cutaneous Vasculitis
First Posted Date
2016-12-28
Last Posted Date
2025-01-14
Lead Sponsor
Peter Merkel
Target Recruit Count
50
Registration Number
NCT03004326
Locations
🇺🇸

University of California, Los Angeles, Los Angeles, California, United States

🇺🇸

Boston University School of Medicine, Boston, Massachusetts, United States

🇺🇸

Mayo Clinic, Rochester, Minnesota, United States

and more 6 locations

Use of MRI and PET for Assessing Disease Activity in Takayasu's Arteritis

Completed
Conditions
Takayasu Arteritis
First Posted Date
2008-09-01
Last Posted Date
2018-10-19
Lead Sponsor
Peter Merkel
Target Recruit Count
26
Registration Number
NCT00744952
Locations
🇺🇸

Boston University School of Medicine, Boston, Massachusetts, United States

🇺🇸

Mayo Clinic, Rochester, Minnesota, United States

🇺🇸

Cleveland Clinic Foundation, Cleveland, Ohio, United States

and more 2 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.